Estimates Revisions Basilea Pharmaceutica AG
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
|
Real-time Estimate
Cboe Europe
10:21:34 23/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 68.85 CHF | +0.36% |
|
+3.61% | +25.96% |
| 14/09 | Japanese Stocks Fall on AI Development Slowdown Calls; Oil Gains | MT |
| 14/09 | Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- BSLN Stock
- Consensus Basilea Pharmaceutica AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
